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Detection of Melanoma Micrometastases – the Power of PCR
Sentinel lymph node biopsy has been recently advocated as a way
to determine whether lymph node dissection would be necessary
as part of the surgical treatment of melanoma. This concept is based
on the notion that the ‘‘sentinel lymph node’’, the first lymph node
of the draining site of the primary tumor, is never bypassed in
malignant melanoma. Thus, lack of metastases in the sentinel lymph
node has been considered a good prognostic finding. In this issue,
Lukowsky et al (p. 554) have evaluated this concept by examining
the regional lymph nodes, sentinel and nonsentinel, in 24 patients
with malignant melanoma by histopathology and immunohistochem-
istry, and compared these results for the presence of tyrosinase
mRNA as determined by RT-PCR. Because the tyrosinase gene is
expressed exclusively in melanocytic cells, detection of the corres-
ponding transcripts would signify the presence of metastases in the
tissue. As expected, 10 of 20 patients with histologic evidence of
Type XIII, a Transmembrane Protein in the Epidermis
Collagens comprise a superfamily of proteins, and as many as 20
different mammalian collagens have been studied thus far to the extent
that they have been designated by a Roman numeral. Among these
20 collagens, at least a dozen have been demonstrated in the skin. In
this issue, Peltonen et al (p. 635) have examined the localization of
another collagen, type XIII, which has recently been shown to be a
transmembrane protein. Using a variety of immunologic and molecular
biologic techniques, the authors demonstrate that type XIII collagen
is expressed in the epidermis in various contact sites. Specifically,
colocalization studies suggested that type XIII collagen is not a member
of the desmosome, but is likely to be associated with adherens type
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metastasis in the sentinel lymph node were also positive for tyrosinase
mRNA, as were three additional patients without morphologic
evidence, attesting to the sensitivity of the RT-PCR approach.
Surprisingly, however, in seven patients RT-PCR was clearly positive
for tyrosinase mRNA in nonsentinel lymph nodes, whereas the
sentinel lymph node was negative. Assuming the specificity of the
PCR for tyrosinase, it appears that the sentinel lymph node biopsy
may miss micrometastases that have spread beyond the primary
tumor and somehow bypassed the sentinel lymph node. These
results clearly warrant further studies to validate the concept of
sentinel lymph node biopsy. They also suggest that incorporation
of RT-PCR into the armamentoire to examine regional lymph
nodes in patients with malignant melanoma increases the sensitivity
for detection of metastases
junctions. Previously, another collagen, type XVII collagen, has been
shown to be a keratinocyte gene product, in type 2 transmembrane
orientation and a component of hemidesmosomes. Type XVII collagen
clearly confers stability to the dermal–epidermal basement membrane
zone, as mutations in the corresponding gene (COL17A1) underlie a
non-Herlitz type of junctional epidermolysis bullosa, known as general-
ized atrophic benign EB (GABEB). The functional role of type XIII
collagen within the epidermis is currently unknown, but the authors
speculate that, in analogy with type XVII collagen, aberrations in this
collagen may be associated with heritable and/or acquired blistering
skin diseases.
